Bandingkan Harga & Kinerja Sinar Terang Mandiri Tbk. (MINE) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sinar Terang Mandiri Tbk. dan Organon Pharma Indonesia Tbk.: Sinar Terang Mandiri Tbk. diperdagangkan di Rp286 (kapitalisasi pasar 1,14 T, volume 24 jam 2,03 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sinar Terang Mandiri Tbk. jauh lebih besar — sekitar 10,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MINE | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,14 T | 104,4 M |
Volume | 2,03 jt | — |
Lot | 20,25 rb | — |
Perputaran | 565,3 jt | — |
Harga Rata-rata | 279,12 | — |
Nilai Transaksi | 565,3 jt | — |
Harga Ekuilibrium Indikatif | 286 | — |
Volume Ekuilibrium Indikatif | 770 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sinar Terang Mandiri Tbk.
PT Sinar Terang Mandiri Tbk (the Company) was established based on Notarial Deed No. 6 dated 22 December 2004 of Winar Sianet, S.H., Notary in Manado. The parent entity as well as the ultimate parent of the Company is PT Mitra Berkarya Sukses Selalu.
Selengkapnya di halaman MINE →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
